combining anti-her2 agents with immunotherapy for her2 mbc
Published 4 years ago • 1.2K plays • Length 6:06Download video MP4
Download video MP3
Similar videos
-
5:46
treating her2 mbc: immunotherapy and tkis
-
1:06
immunotherapy combination in her2-positive breast cancer
-
1:37
dr. bhave on promising anti-her2 agents in her2 breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
9:30
1 1 = 3. combined use of anti-her2 agents in the neoadjuvant setting
-
0:22
copy of dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
1:54
dr. khong on endocrine combinations in er /her2- breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
6:09
emerging agents for her2 mbc: targeted therapeutics
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:24
dr. yardley on emerging agents in her2-positive breast cancer
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
8:21
stereotactic radiosurgery in combination with anti-her2 therapy for her2 breast cancer brain mets
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
3:44
relapsed/refractory her2 mbc: future treatment landscape
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
0:34
her2-targeted therapies